SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Twist Bioscience Is Maintained at Outperform by Leerink Partners

Ratings actions from Benzinga: GMT) Twist Bioscience Price Target Raised to $190.00/Share From $160.00 by Leerink PartnersRatings actions from Benzinga

TWST

Related stories